It was confirmed by a White House adviser. It is the vaccine developed by the pharmaceutical company Pfizer and its German partner BioNTech.
The United States already has a date-listed plan to begin vaccinating its population against the coronavirus. This Sunday, an adviser to the White House reported that he hopes that the first Americans can begin to apply it at the earliest next December 12.
This was predicted by Moncef Slaoui, the main adviser of Operation “Warp Speed”, the US government team that tries to accelerate medical solutions to the pandemic.
The start of the vaccination will depend on what the advisers of the US Food and Drug Administration (FDA) decide, which will meet on December 10 to decide whether to approve the vaccine developed by the pharmaceutical company Pfizer and its German partner BioNTech. The request for emergency authorization started last Friday for use in the United States.
If they give it the go-ahead that same day, the US government is “ready to start delivering vaccines within 24 hours following its approval, “Slaoui said in an interview with ABC News.
“We will have the (first) vaccines (distributed) one day after approval, and we hope that people can start being immunized, I would say within 48 hours of approval“That is, on December 12, Slaoui added.
If that happens, the expert calculated that the United States could return to the closest thing to a new normal “sometime in May” in 2021, when he estimated that 70% of the population will have received the vaccine and a group immunity.
According to the initial plan, the first vaccines will be distributed proportionally to the population of each state, and those territories will be able to decide who will have priority to receive them. It is estimated that the first will be the high-risk population and medical professionals, Slaoui explained.
The Trump administration gave few details about how it will face the challenge of vaccinating the more than 330 million inhabitants of the United States, and did not share its plans with the team of President-elect Joe Biden, who warned that such a lack of cooperation can cost lives in the country.
According to the plan estimates that Slaoui gave, the first vaccines could begin to be administered more than a month before Biden takes office of his position, next January 20.
But there will be a problem at the door in the North American country: only 58% of citizens are willing to have the vaccine administeredaccording to a poll released this week by Gallup. For that reason the plan of herd vaccination and immunization is at risk.
Pfizer’s vaccine requires two doses given about three weeks apart, and has shown up to 95% efficacy in preliminary clinical trials, without major safety concerns.
The United States has another candidate who also demonstrated the effectiveness of its vaccine, that of the pharmaceutical company Moderna, which could request emergency authorization shortly and that, unlike Pfizer, owes part of the injection of funds from the United States Government of its success in the historically rapid development process of the preparation.
The North American country is in the midst of a rebound in covid-19 infections: it has already exceeded 12 million cases of coronavirus and has already added more than 255,000 deaths, more than any other country in the world.
With information from EFE.